Anti-Diabetic Therapies and Cancer: From Bench to Bedside
D Kounatidis, NG Vallianou, I Karampela, E Rebelos… - Biomolecules, 2024 - mdpi.com
Diabetes mellitus (DM) is a significant risk factor for various cancers, with the impact of anti-
diabetic therapies on cancer progression differing across malignancies. Among these …
diabetic therapies on cancer progression differing across malignancies. Among these …
Carrier-free delivery of thymopentin-regulated injectable nanogels via an enhanced cancer immunity cycle against melanoma metastasis
N Ding, K He, H Tian, L Li, Q Li, S Lu, K Ding, J Liu… - Materials Today Bio, 2023 - Elsevier
Abstract Thymopentin (TP5), a clinically used immunomodulatory pentapeptide, can
efficiently promote thymocyte differentiation and influence mature T-cell function, thus …
efficiently promote thymocyte differentiation and influence mature T-cell function, thus …
RNA binding protein PUM2 promotes IL-1β-induced apoptosis of chondrocytes via regulating FOXO3 expression
D Wang, ZL Zhang, X Li, L He - Heliyon, 2024 - cell.com
Objective RNA-binding proteins (RBPs) have been recently proven to be involved in the
pathogenesis of several diseases. However, few studies elaborated RBPs in regulating …
pathogenesis of several diseases. However, few studies elaborated RBPs in regulating …